OBJECTIVE: We aimed to study the influence of carbapenem resistance on attributable mortality in a cohort of patients with Pseudomonas aeruginosa bacteremia. METHODS: Data on 121 episodes of P. aeruginosa bacteremia occurring between January and December 2005 were retrospectively analyzed. RESULTS: Thirty-three episodes were caused by carbapenem-resistant P. aeruginosa (CRPA) strains and 88 by carbapenem-susceptible P. aeruginosa (CSPA) strains. There was no significant difference in mortality between the groups (33% in CRPA vs. 30% in CSPA; p = 0.69). However, a Kaplan-Meier survival analysis showed that in the first 48h after the onset of bacteremia, there was a lower cumulative mortality proportion in the CRPA group than in the CSPA group (13% vs. 50%; p = 0.026). The independent risk factors associated with death in P. aeruginosa bacteremia were clinical presentation with severe sepsis (odds ratio (OR) 38, 95% confidence interval (CI) 10.2-142.2) and bacteremia of high-risk origin (OR 6.6, 95% CI 1.6-26.9). CONCLUSIONS: According to our data, carbapenem resistance was not associated with higher mortality in patients with P. aeruginosa bacteremia. The slower initial mortality in the CRPA group might have implications in the design of the optimal antibiotic policy strategy.
OBJECTIVE: We aimed to study the influence of carbapenem resistance on attributable mortality in a cohort of patients with Pseudomonas aeruginosa bacteremia. METHODS: Data on 121 episodes of P. aeruginosa bacteremia occurring between January and December 2005 were retrospectively analyzed. RESULTS: Thirty-three episodes were caused by carbapenem-resistant P. aeruginosa (CRPA) strains and 88 by carbapenem-susceptible P. aeruginosa (CSPA) strains. There was no significant difference in mortality between the groups (33% in CRPA vs. 30% in CSPA; p = 0.69). However, a Kaplan-Meier survival analysis showed that in the first 48h after the onset of bacteremia, there was a lower cumulative mortality proportion in the CRPA group than in the CSPA group (13% vs. 50%; p = 0.026). The independent risk factors associated with death in P. aeruginosa bacteremia were clinical presentation with severe sepsis (odds ratio (OR) 38, 95% confidence interval (CI) 10.2-142.2) and bacteremia of high-risk origin (OR 6.6, 95% CI 1.6-26.9). CONCLUSIONS: According to our data, carbapenem resistance was not associated with higher mortality in patients with P. aeruginosa bacteremia. The slower initial mortality in the CRPA group might have implications in the design of the optimal antibiotic policy strategy.
Authors: Deanna J Buehrle; Ryan K Shields; Lloyd G Clarke; Brian A Potoski; Cornelius J Clancy; M Hong Nguyen Journal: Antimicrob Agents Chemother Date: 2016-12-27 Impact factor: 5.191
Authors: Carmen Peña; Cristina Suarez; Mónica Gozalo; Javier Murillas; Benito Almirante; Virginia Pomar; Manuela Aguilar; Ana Granados; Esther Calbo; Jesús Rodríguez-Baño; Fernando Rodríguez; Fe Tubau; Luis Martínez-Martínez; Antonio Oliver Journal: Antimicrob Agents Chemother Date: 2011-12-12 Impact factor: 5.191
Authors: Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos Journal: Antimicrob Agents Chemother Date: 2014-02-18 Impact factor: 5.191
Authors: Raúl Recio; Irina Sánchez-Diener; Esther Viedma; María Ángeles Meléndez-Carmona; Jennifer Villa; María Ángeles Orellana; Mikel Mancheño; Carlos Juan; Laura Zamorano; Jaime Lora-Tamayo; Fernando Chaves; Antonio Oliver Journal: Eur J Clin Microbiol Infect Dis Date: 2019-12-10 Impact factor: 3.267
Authors: Youn Jeong Kim; Yoon Hee Jun; Yang Ree Kim; Kang Gyun Park; Yeon Joon Park; Ji Young Kang; Sang Il Kim Journal: BMC Infect Dis Date: 2014-03-24 Impact factor: 3.090
Authors: M Colomb-Cotinat; J Lacoste; C Brun-Buisson; V Jarlier; B Coignard; S Vaux Journal: Antimicrob Resist Infect Control Date: 2016-12-12 Impact factor: 4.887